FDA warning letter prompts coverage of repeat Baxter production deficiencies

On October 22, Fierce Pharma reported that FDA’s September 29 warning letter cited production violations at Baxter’s Round Lake plant, inspected March 23–April 2, and linked some findings to three recalls earlier in 2026. FDA also noted similar violations at other Baxter sites.